Company profile: ThreeWire
1.1 - Company Overview
Company description
- Provider of customized clinical trial recruitment, enrollment and retention solutions for the pharmaceutical, biotech and medical device industries, addressing enrollment targets and study delays, and offering direct-to-patient marketing services for medical device companies.
Products and services
- Clinical Trial Recruitment & Retention Systems: Customized program that simplifies participant recruitment and retention, addressing enrollment targets and study delays for pharmaceutical, biotech, and medical device trials
- Enrollment Management Services: Industry-specific enrollment support that engineers trial enrollment programs to meet enrollment targets and reduce study delays across pharmaceutical, biotech, and medical device clinical trials
- Direct-to-Patient Marketing Services: Direct-to-patient outreach for medical device companies, delivering marketing services that support clinical trial recruitment and retention.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ThreeWire
Jubilee Clinical Research
HQ: United States
Website
- Description: Provider of clinical research across diverse indications, including new antibiotic developments and the latest diabetic therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jubilee Clinical Research company profile →
Padagis
HQ: United States
Website
- Description: Provider of generic Rx and OTC pharmaceuticals, including Brinzolamide Ophthalmic Suspension for ocular hypertension/open-angle glaucoma, Naloxone HCl Nasal Spray for opioid overdose, and extended topical prescription creams, ointments, suspensions, gels, foams, sprays, patches, nasal, and suppositories. Offers Paragraph IV specialty products and U.S. and Israel manufacturing and distribution across multiple dosage forms, including controlled substances.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Padagis company profile →
Life Science Connect
HQ: United States
Website
- Description: Provider of life science content marketing and sales enablement services, offering the Templeton Customer Insights Platform for purchasing journey insights and content optimization; the Follow Your Buyer Methodology; custom newsletters; Enhanced Lead Intelligence (ELI) reports; and content services including creation and distribution via webinars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Life Science Connect company profile →
Orange Grove Bio
HQ: United States
Website
- Description: Provider of a preclinical drug investment and development platform focused on reducing drug discovery costs and advancing therapies to clinical trials, offering direct sourcing and comprehensive diligence processes, seasoned operations teams, licensing via academic collaborations, and technologies such as Preservation Bio's platelet additive and Genexys BioMed's gene therapy platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orange Grove Bio company profile →
Aiolos Bio
HQ: United States
Website
- Description: Provider of therapies for respiratory and immune conditions, initially advancing AIO-001, a monoclonal antibody for moderate-to-severe asthma dosed every 6 months. Offers vaccines for meningitis, shingles, RSV, flu, and polio; specialty and general medicines for HIV, asthma, COPD, lupus, cancer, and skin diseases; conducts infectious disease research and develops respiratory/immunology solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aiolos Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ThreeWire
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ThreeWire
2.2 - Growth funds investing in similar companies to ThreeWire
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ThreeWire
4.2 - Public trading comparable groups for ThreeWire
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →